Stockholm, Sweden — Medivir AB (OMX: MVIR) today announces that a Capital Markets Meeting will be arranged for investors, analysts and...
Read moreVoluntary redemption programme The Extraordinary General Meeting in Medivir Aktiebolag (publ) on 2 February 2017 resolved, in accordance with the Board...
Read moreStockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the independent Data Monitoring Committee (DMC) held its fourth and...
Read moreThe shareholders in Medivir AB are hereby summoned to the Extraordinary General Meeting on Thursday 2 February 2017 at 2.00 p.m....
Read moreStockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) is conducting an analyst and investor conference call/webcast today, 9th January 2017, at...
Read more